Deregulation of intestinal immune responses seems to have a principal function in the
pathogenesis of inflammatory bowel disease 1 , 2 , 3 , 4 . The gut epithelium is critically involved …

Background Gut-selective blockade of lymphocyte trafficking by vedolizumab may constitute
effective treatment for ulcerative colitis. Methods We conducted two integrated randomized, …

Background The efficacy of ustekinumab, an antagonist of the p40 subunit of interleukin-12
and interleukin-23, as induction and maintenance therapy in patients with ulcerative colitis is …

Importance Case reports and series suggest hematopoietic stem cell transplantation (HSCT)
may benefit some patients with Crohn disease. Objective To evaluate the effect of …

This paper is the second in a series of two publications relating to the European Crohn’s
and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and …

Background The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
initiative of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD…

Background Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have
potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial. We further …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) pandemic
is a worldwide emergency. An increasing number of diarrhea cases is reported. Here we …

Crohn’s disease is an inflammatory bowel disease that is characterized by chronic inflammation
of any part of the gastrointestinal tract, has a progressive and destructive course and is …

Background Ozanimod, a selective sphingosine-1-phosphate receptor modulator, is under
investigation for the treatment of inflammatory bowel disease. Methods We conducted a …